Analyst Price Targets — EHC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 22, 2026 10:20 am | Whit Mayo | Leerink Partners | $152.00 | $104.45 | StreetInsider | Encompass Health Corp (EHC) PT Raised to $152 at Leerink |
| May 5, 2026 8:58 am | — | Barclays | $140.00 | $106.64 | TheFly | Encompass Health price target lowered to $140 from $153 at Barclays |
| February 6, 2026 10:32 am | — | Barclays | $153.00 | $99.56 | TheFly | Encompass Health price target raised to $153 from $150 at Barclays |
| October 30, 2025 10:21 am | Andrew Mok | Barclays | $150.00 | $125.63 | TheFly | Encompass Health price target raised to $150 from $141 at Barclays |
| October 2, 2025 11:56 am | — | UBS | $150.00 | $124.52 | TheFly | Encompass Health price target raised to $150 from $140 at UBS |
| August 14, 2025 11:04 am | David MacDonald | Truist Financial | $140.00 | $119.30 | TheFly | Encompass Health price target raised to $140 from $135 at Truist |
| April 28, 2025 12:59 pm | — | RBC Capital | $125.00 | $115.32 | TheFly | Encompass Health price target raised to $125 from $110 at RBC Capital |
| September 26, 2024 8:09 am | Ben Hendrix | RBC Capital | $105.00 | $96.75 | TheFly | Encompass Health price target raised to $105 from $95 at RBC Capital |
| September 25, 2024 7:39 am | AJ Rice | UBS | $110.00 | $95.26 | TheFly | Encompass Health price target raised to $110 from $100 at UBS |
| May 22, 2024 6:16 am | Frank Morgan | RBC Capital | $95.00 | $85.86 | StreetInsider | Encompass Health Corp (EHC) PT Raised to $95 at RBC Capital |
Latest News for EHC
BIRMINGHAM, Ala., July 9, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its second quarter ended June 30, 2026, after the market closes on Wednesday, Aug. 5, 2026.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
EHC is accelerating hospital and bed expansions to boost capacity, with execution now key as stronger results support higher 2026 EPS guidance.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
DaVita operates more than 3,200 dialysis centers globally, serving roughly 295,000 patients with a dominant market share in kidney care. Encompass Health is a leader in inpatient rehabilitation with double-digit revenue growth and higher net margins than its peer in this matchup.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EHC.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.